Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Human hair follicle stem cells can turn into multiple cell types but lose some of this ability after being grown in the lab for a long time.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

New therapies for burn wounds show promise in reducing pain, infection risk, and improving healing and physical outcomes.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Innovative biomaterials show promise in healing chronic diabetic foot ulcers.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.